Funder
Henan Provincial Science and Technology Research Project
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Morice, P., Leary, A., Creutzberg, C., Abu-Rustum, N., & Darai, E. (2016). Endometrial cancer. Lancet, 387, 1094–1108.
2. Capaci, V., Monasta, L., Aloisio, M., Sommella, E., Salviati, E., Campiglia, P., Basilicata, M. G., Kharrat, F., Licastro, D., Di Lorenzo, G., & Romano, F. (2023). A Multi-omics approach revealed common dysregulated pathways in type one and type two endometrial cancers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216057
3. Siegel, R. L., Miller, K. D., & Jemal, A. (2019). Cancer statistics, 2019. CA: A Cancer Journal for Clinicians, 69, 7–34.
4. Li, X., Zheng, S., Chen, S., Qin, F., Lau, S., & Chen, Q. (2015). Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013. Tumour Biology, 36, 4961–4966.
5. Arend, R. C., Jones, B. A., Martinez, A., & Goodfellow, P. (2018). Endometrial cancer: Molecular markers and management of advanced stage disease. Gynecologic Oncology, 150, 569–580.